EVC
Eidelman Virant Capital’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.97M | Hold |
41,275
| – | – | 2.18% | 7 |
|
|
2022
Q2 | $3.04M | Sell |
41,275
-2,700
| -6% | -$199K | 2.19% | 6 |
|
|
2022
Q1 | $3.21M | Sell |
43,975
-36,770
| -46% | -$2.68M | 1.73% | 12 |
|
|
2021
Q4 | $5.06M | Sell |
80,745
-1,065
| -1% | -$66.7K | 1.83% | 10 |
|
|
2021
Q3 | $4.9M | Sell |
81,810
-925
| -1% | -$55.4K | 1.88% | 9 |
|
|
2021
Q2 | $5.54M | Sell |
82,735
-12,195
| -13% | -$816K | 2.13% | 10 |
|
|
2021
Q1 | $6.01M | Buy |
94,930
+87,210
| +1,130% | +$5.52M | 2.42% | 9 |
|
|
2020
Q4 | $479K | Sell |
7,720
-1,700
| -18% | -$105K | 0.21% | 90 |
|
|
2020
Q3 | $567K | Sell |
9,420
-1,650
| -15% | -$99.3K | 0.31% | 64 |
|
|
2020
Q2 | $651K | Buy |
+11,070
| New | +$651K | 0.46% | 47 |
|